Brind.

Soligenix, Inc. collaborated with John A. Burns School of Medicine on vaccine development relevant for virus-endemic countries in Africa.

Steady: 1 in the last 7 days Updated saturday

The latest in this situation

  1. CEPI provided support for the Tumaini trial, where a Merck vaccine is being administered in the Democratic Republic of the Congo.

How it started

1 report, 1 independent, last reported May 26. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Soligenix, Inc. collaborated with John A. Burns School of Medicine on vaccine development relevant for virus-endemic countries in Africa.

Who's involved

What this event is mainly about
John A. Burns School of MedicineAfrica

How it developed

Newest first. Tap a step to see who reported it.
  1. Vaccine trials are being conducted in Africa, alongside WHO estimates of the disease burden.Sub-event
  2. Soligenix and a medical school announced a collaboration on vaccine development for Africa.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped